STERIS plc (STE)
- Previous Close
200.90 - Open
201.85 - Bid 82.71 x 1300
- Ask 208.95 x 800
- Day's Range
201.56 - 208.02 - 52 Week Range
180.54 - 254.00 - Volume
561,633 - Avg. Volume
486,025 - Market Cap (intraday)
20.355B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
36.20 - EPS (TTM)
5.69 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield 2.08 (1.01%)
- Ex-Dividend Date Feb 22, 2024
- 1y Target Est
239.86
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
www.steris.comRecent News: STE
Performance Overview: STE
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STE
Valuation Measures
Market Cap
20.35B
Enterprise Value
23.67B
Trailing P/E
36.20
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.80
Price/Book (mrq)
3.17
Enterprise Value/Revenue
4.38
Enterprise Value/EBITDA
16.98
Financial Highlights
Profitability and Income Statement
Profit Margin
10.48%
Return on Assets (ttm)
4.77%
Return on Equity (ttm)
9.11%
Revenue (ttm)
5.41B
Net Income Avi to Common (ttm)
566.84M
Diluted EPS (ttm)
5.69
Balance Sheet and Cash Flow
Total Cash (mrq)
195.58M
Total Debt/Equity (mrq)
54.59%
Levered Free Cash Flow (ttm)
524.2M
Research Analysis: STE
Company Insights: STE
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: STE
STE: Lowering target price to $209.00
STERIS PLC has an Investment Rating of HOLD; a target price of $209.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetSTE: Lowering target price to $225.00
STERIS PLC has an Investment Rating of HOLD; a target price of $225.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetSTE: Lowering target price to $227.00
STERIS PLC has an Investment Rating of HOLD; a target price of $227.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetSTE: Lowering target price to $233.00
STERIS PLC has an Investment Rating of HOLD; a target price of $233.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target